Craft

Eikon Therapeutics

Eikon Therapeutics Summary

Company Summary

Overview
Eikon Therapeutics is a biopharmaceutical company that provides a method of drug discovery based on tracking and measuring the movement of individual proteins in live cells. It uses the method to develop therapeutics for oncology, immunology, and neuroscience.
Type
Public
Status
Active
Founded
2019
HQ
Millbrae, CA, US | view all locations
Website
https://www.eikontx.com
Cybersecurity rating
Sectors

Key People

  • Roger Perlmutter

    Roger Perlmutter, Chief Executive Officer

  • Alfred Bowie

    Alfred Bowie, Chief Financial Officer

  • Russ Berman

    Russ Berman, Chief Technical Officer

  • Ashish Kheterpal

    Ashish Kheterpal, Chief Information Officer

LocationsView all

4 locations detected

  • Millbrae, CA HQ

    United States

    230 Harriet Tubman Way

  • Hayward, CA

    United States

    24590 Clawiter Road

  • Jersey City, NJ

    United States

    3 2nd St, 4th Floor

  • New York, NY

    United States

    450 East 29th St @ 1st Ave, 15th Floor

Eikon Therapeutics Financials

Summary Financials

Net income (Q1, 2026)
($83.0M)
Cash (Q1, 2026)
$161.2M
EBIT (Q1, 2026)
($87.3M)

Footer menu